✦ LIBER ✦

Blockade of 5-HT2A/2C-Type Receptors Impairs Learning in Female Rats in the Course of Estrous Cycle

✍ Scribed by Yu. O. Fedotova; N. E. Ordyan

Book ID: 106358808
Publisher: Springer US
Year: 2010
Tongue: English
Weight: 380 KB
Volume: 150
Category: Article
ISSN: 0007-4888
DOI: 10.1007/s10517-010-1053-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of an Agonist and an Antagonist

Effects of an Agonist and an Antagonist of 5-HT1ASerotonin Receptors on Learning in Female Rats during the Ovarian Cycle

✍ Yu. O. Fedotova; N. E. Ordyan 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 136 KB

Antihypertensive effects of chronic 5-hy

Antihypertensive effects of chronic 5-hydroxytryptamine (5-HT2) receptor blockade with irindalone in the spontaneously hypertensive rat

✍ K. Gradin; T. Hedner; B. Persson 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 441 KB

5-HT2C receptors are involved in the dis

5-HT2C receptors are involved in the discriminative stimulus effects of citalopram in rats

✍ M. J. Millan; S. Girardon; A. Dekeyne 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 29 KB

Mechanism of tolerance development to 2,

Mechanism of tolerance development to 2,5-dimethoxy-4-iodoamphetamine in rats: down-regulation of the 5-HT2A, but not 5-HT2C, receptor

✍ R. L. Smith; Robert J. Barrett; Elaine Sanders-Bush 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 91 KB

Effects of blockade of 5-HT2receptors an

Effects of blockade of 5-HT2receptors and activation of 5-HT1Areceptors on the exploratory activity of rats in the elevated plus-maze

✍ Vítor Motta; S. Maisonnette; S. Morato; P. Castrechini; M. L. Brandão 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 580 KB

Distribution of serotonin 5-HT2A recepto

Distribution of serotonin 5-HT2A receptors in afferents of the rat striatum

✍ Michael Bubser; Jon R. Backstrom; Elaine Sanders-Bush; Bryan L. Roth; Ariel Y. D 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 366 KB 👁 3 views

Treatment with conventional antipsychotic drugs (APDs) is accompanied by extrapyramidal side effects (EPS), which are thought to be due to striatal dopamine D(2) receptor blockade. In contrast, treatment with atypical APDs is marked by a low incidence or absence of EPS. The reduced motor side effect